Le Lézard
Classified in: Health, Science and technology
Subject: PER

TARA Biosystems Appoints Pharmaceutical Industry Innovation Leader, John M. Baldoni, Ph.D., to Its Board of Directors


NEW YORK, Feb. 20, 2018 /PRNewswire/ -- TARA Biosystems, Inc., a company offering physiologically relevant "heart-on-a-chip" tissue models for drug discovery and development applications, announced today that it has appointed pharmaceutical industry innovation leader, John M. Baldoni, Ph.D. to its Board of Directors. 

TARA Biosystems offers bioanalytical testing services on its human stem cell-derived cardiac tissue platform. The company's Biowiretm II platform enables early cardiac risk assessment of drug discovery candidates and accelerates discovery efforts for novel heart medicines via its disease modeling and phenotypic screening capabilities. TARA continues to develop a proprietary analytics platform, leveraging data from internal development programs on its Biowiretm II tissue production platform.  

"TARA Biosystems uniquely enables the production of large amounts of high fidelity human-relevant data," said Dr. Baldoni. "This provides foundational information for machine learning and next-generation computational approaches that are fundamentally shifting the way drug development is done today."

Dr. Baldoni has over 37 years of experience in implementing cutting-edge technology to improving the development of new medicines. He is currently Senior Vice President of In silico Drug Discovery, at GSK, which uses computational methods to identify patient needs, explore molecular interventions to address those needs, and design clinical trials to test the medical hypothesis. The intent is to discover medicines at a higher velocity and with greater precision compared to current approaches. Dr. Baldoni is also a founder and governing board co-chairperson of Accelerating Therapeutics for Opportunities in Medicine (ATOM), which is championing a framework for pioneering applications of deep learning for drug research. ATOM aims to develop computing models that will guide researchers based on a computer's ability to quickly vet millions of molecules for efficacy and structural relationships and that will adapt as they are applied to new data. Dr. Baldoni was previously Senior Vice President, Platform Technology, and Science, at GSK. In that role, he worked across the entire drug discovery and development process.

"TARA's objective is to greatly improve the drug discovery and development process by providing human in vitro models," said Misti Ushio, Ph.D., Chief Executive Officer of TARA. "Dr. Baldoni brings to TARA a visionary perspective on how engineered human cardiac tissue data can be applied to predictive risk assessment and the acceleration of drug discovery."  

About TARA Biosystems

TARA Biosystems, Inc. provides predictive, in vitro human cardiac tissue models for use in drug discovery and risk assessment. TARA Biosystems offers a high fidelity solution that is based on human iPS cell-derived cardiac tissue matured to physiologically relevant adult-like levels and provides direct measures of cardiac functionality, including contractile force. The TARA platform allows pharma to access human cardiac information on therapeutics candidates earlier in the drug development cycle.

Press Contact: 
Kirsten Thomas
The Ruth Group
508-280-6592
[email protected]

SOURCE TARA Biosystems, Inc.


These press releases may also interest you

at 13:37
Bell Techlogix, an Indianapolis-based IT managed services and solutions company, today announced that CRN, a brand of The Channel Company, has honored Bell Techlogix on its 2024 Tech Elite 250 list....

at 13:30
Waterfield Tech, a leading global customer engagement solutions provider, today announced its new suite of generative AI solutions. This innovative offering enables contact center leaders to build on the promise of AI in their organizations with low...

at 13:30
The "Global Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2024 Update" report has been added to ResearchAndMarkets.com's offering. Global gift card industry is expected to grow by 7.9% on annual basis to...

at 13:20
Coalition, the world's first Active Insurance provider designed to prevent digital risk before it strikes, today announced that Coalition Insurance Company (CIC), the full-stack Active Cyber Insurance carrier, is now open for quoting Coalition's...

at 13:20
Blumira, a leading security and operations platform, today announced tech industry veteran Haiyang Li has joined the company as its vice president of engineering, effective March 18. Li joins the Blumira leadership team with extensive experience...

at 13:16
Risas Dental & Braces ("Risas"), a dental and braces provider that serves patients in Arizona, Colorado, Texas, and Nevada, has learned of a data security incident that may have involved the protected health information of certain Risas patients....



News published on and distributed by: